Willemse, E. A. J. http://orcid.org/0000-0001-9140-4243
Scheltens, P.
Teunissen, C. E.
Vijverberg, E. G. B.
Funding for this research was provided by:
Selfridges Group Foundation (NR180033)
H2020 European Research Council (860303)
Article History
Received: 2 February 2021
Accepted: 4 May 2021
First Online: 18 May 2021
Declarations
:
: All patients included in this study gave written informed consent for the storage of their clinical data for research purposes as part of the Amsterdam Dementia Cohort (ADC) and the ADC was approved by the local medical ethical committee of the VU University Medical Center.
: Not applicable.
: E.A.J.W. and E.G.B.V. report no declarations of interest.P.S. has received consultancy fees (paid to the institution) from AC Immune, Alkermes, Alnylam, Alzheon, Anavex, Biogen, Brainstorm Cell, Cortexyme, Denali, EIP, ImmunoBrain Checkpoint, GemVax, Genentech, Green Valley, Novartis, Novo Nordisk, PeopleBio, Renew LLC, Roche. He is PI of studies with AC Immune, CogRx, FUJI-film/Toyama, IONIS, UCB, Vivoryon. He is a part-time employee of Life Sciences Partners Amsterdam. He serves on the board of the Brain Research Center.C.E.T. has a collaboration contract with ADx Neurosciences and Quanterix, performed contract research or received grants from AxonNeurosciences, Biogen, Boehringer, Brainstorm Therapeutics, Celgene, EIP Pharma, Esai, Janssen prevention center, Roche, Toyama, Vivoryon.